Creatine

Overview

An amino acid derivative that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine.

Indication

For nutritional supplementation, also for treating dietary shortage or imbalance.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
5-HTP and Creatine for Depression R33 Phase	2023/06/09	NCT05895747	Phase 2	Recruiting	University of Utah
Creatine Use and Muscle Stretching in Peripheral Artery Disease	2020/07/15	NCT04471792	Phase 2	Completed	Florida State University
5-HTP and Creatine for Depression	2020/05/20	NCT04395183	Phase 2	Completed	University of Utah
Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males	2018/05/21	NCT03530202	Phase 2	UNKNOWN	University of Regina
Creatine Monohydrate Use for Preventing Altitude Induced Depression	2018/02/14	NCT03433651	Phase 4	Withdrawn	Mike O'Callaghan Military Hospital
Creatine for Treatment of Depression Associated With Type 2 Diabetes	2017/06/28	NCT03202095	Phase 4	Withdrawn	University of Utah
Sodium Creatine Phosphate in Heart Valve Surgery	2017/06/14	NCT03186053	Not Applicable	UNKNOWN	Chinese Academy of Medical Sciences, Fuwai Hospital
Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females	2016/10/04	NCT02922725	Phase 4	Terminated	Brent Michael Kious, MD, PhD
Creatine for Depressed Male and Female Methamphetamine Users	2015/10/06	NCT02568878	Phase 3	Recruiting	Montana State University
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)	2015/06/04	NCT02463305	Early Phase 1	Withdrawn	University of Colorado, Denver

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
MOUTH ULCER	343446	Substance Pty Ltd	Medicine	A	9/14/2020
Wealthy Health R.J. Plus	125152	Universal Pharmaceuticals Pty Ltd	Medicine	A	1/18/2006
ENERGY + FOCUS	464752	Australian Health Vitality Pty Ltd	Medicine	A	10/17/2024
Kynd Australia Collagen + Endo 180	475645	Global Health Initiative Pty Ltd	Medicine	A	1/13/2025
K-OS Pre-Workout Juicy Melon	408413	Body Science International Pty Ltd	Medicine	A	5/3/2023
BioHack Wanderlust Energy Optimiser	488931	Wanderlust Products Pty Ltd	Medicine	A	5/15/2025
Muscle Builder Tablets	134847	Enervite (NSW) Pty Ltd	Medicine	A	2/12/2007
Creatine Chewables	485028	ATP Science Pty Ltd	Medicine	A	4/2/2025
Pre-Workout Tropical Mango	462400	Australian Health Vitality Pty Ltd	Medicine	A	9/19/2024
MUSASHI CREATINE MONOHYDRATE 1g/g oral powder	51611	Musashi Pty Ltd	Medicine	A	2/17/1995

Related News

Novel Compound SANA Shows Promise in Phase 1 Clinical Trial for Obesity Treatment Through Unique Thermogenesis Mechanism

2 months ago

SANA, a derivative of salicylate, demonstrated weight loss and improved insulin resistance in healthy, overweight, and obese volunteers during a phase 1 clinical trial with doses up to 800 mg.

Nitches, Inc. Enters Bioceutical Market with Launch of InTheZone Labs

9 months ago

• Nitches, Inc. has launched InTheZone Labs, a new vertical focused on bioceutical and nutraceutical products designed to enhance mental focus, vitality, and cognitive development. • The initial product line includes InTheZone Focused, InTheZone Passion, and InTheZone Focused Youth, targeting professionals, adults seeking vitality, and students, respectively. • A Phase One Study, led by medical experts and former NFL athletes, is planned to validate the effectiveness of the InTheZone Labs product line. • Nitches aims to capitalize on the growing nutraceutical and bioceutical market, projected to reach $650 billion by 2027, through its new InTheZone Labs division.

Help Us Improve

Your feedback helps us provide better drug information and insights.

AI-Powered Research

Premium Access